feed,title,long_url,short_url
Benzinga,DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies,https://benzinga.com/general/biotech/23/08/33487292/dbv-technologies-advances-peanut-allergy-program-with-fda-support-on-pediatric-studies,https://da.gd/OxLXcM
Benzinga,"Merck Swings Into Q2 Loss On Prometheus Biosciences Acquisition Charge, But Raises FY23 Revenue Outlook",https://benzinga.com/general/biotech/23/08/33491400/merck-swings-into-q2-loss-on-prometheus-biosciences-acquisition-charge-but-raises-fy23-revenue-ou,https://da.gd/YfsxK
